You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动 | 药明康德盘中涨超11%创新高,预计2020年净利同比增长50%到60%
uSMART盈立智投 01-22 09:47

uSMART盈立智投1月22日消息,周五港股早盘,药明康德高开高走,截至9:46分,药明康德盘中涨超11%,股价最高触及203.8港元,创历史新高。

昨日港股盘后,药明康德发布盈利预告称,公司预计2020年年度归属于公司股东的净利润与2019年年度的18.55亿元(单位:人民币,下同)相比,增加9.27亿元到11.12亿元,同比增长50%到60%。

公司预计2020年年度实现归属于公司股东的扣除非经常性损益的净利润与2019年年度的19.14亿元相比,同比增长20%到25%。

公司预计2020年年度经调整的非《国际财务报告准则》下归属于公司股东的净利润与2019年年度的24.07.4亿元相比,同比增长45%到50%。

在2020年公司美国区实验室服务和临床合同研究服务(CRO)的收入受到新冠疫情负面影响的情况下,公司中国区实验室服务和合同研发与生产业务(CDMO)自2020年第二季度起全面恢复正常运营。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account